Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors
about
A human scFv antibody that targets and neutralizes high molecular weight pathogenic amyloid-β oligomers.Strategies for Bispecific Single Chain Antibody in Cancer Immunotherapy.Anti-GD2 immunotherapy for neuroblastoma.The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy.
P2860
Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Successful engineering of a hi ...... glioside (GD2) positive tumors
@en
Successful engineering of a highly potent single-chain variable-fragment
@nl
type
label
Successful engineering of a hi ...... glioside (GD2) positive tumors
@en
Successful engineering of a highly potent single-chain variable-fragment
@nl
prefLabel
Successful engineering of a hi ...... glioside (GD2) positive tumors
@en
Successful engineering of a highly potent single-chain variable-fragment
@nl
P2093
P2860
P1433
P1476
Successful engineering of a hi ...... glioside (GD2) positive tumors
@en
P2093
Mahiuddin Ahmed
Ming Cheng
Morgan Huse
Nai-Kong V Cheung
P2860
P304
P356
10.1080/2162402X.2016.1168557
P577
2016-05-05T00:00:00Z